tiprankstipranks
Trending News
More News >
Afya (AFYA)
NASDAQ:AFYA
US Market

Afya (AFYA) Earnings Dates, Call Summary & Reports

Compare
134 Followers

Earnings Data

Report Date
Aug 14, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.34
Last Year’s EPS
2.29
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 09, 2025
|
% Change Since: -2.73%
|
Next Earnings Date:Aug 14, 2025
Earnings Call Sentiment|Positive
Afya reported strong financial performance with significant revenue, EBITDA growth, and strategic achievements like credit rating upgrades and ESG recognition. However, challenges such as a decrease in residency journey students and active users in the Medical Practice Solution segment, along with increased tax expenses, were noted.
Company Guidance
During Afya's first conference call of 2025, the company highlighted several key financial metrics and strategic developments. The net revenue for the first quarter increased by 16% year-over-year, reaching R$936 million, with adjusted EBITDA rising by nearly 24% to R$492 million, resulting in a record margin of 52.5%. Net income also saw significant growth, up 23% to R$257 million, contributing to an EPS of R$2.79. The company reported a strong cash flow from operating activities of R$470 million, reflecting a 10% increase from the previous year and a cash conversion rate of 96.8%. Operationally, the number of approved medical seats rose by 12% to 3,593, and the number of Undergrad Medical students grew by nearly 50%, reaching almost 26,000. The Continuing Education segment saw a 9% organic increase in net revenue to R$71 million, while the Medical Practice Solution segment experienced 14% growth, reaching R$42 million. Additionally, Afya's Ecosystem expanded to include 317,000 active users. The company's financial discipline was further underscored by a national credit rating upgrade to AAA.br by Moody's, a first ESG rating of BBB from MSCI, and a net debt reduction to R$1,524 million by the end of the first quarter.
Strong Revenue and EBITDA Growth
Net revenue increased by 16% year-over-year to R$936 million, while adjusted EBITDA grew by almost 24% to R$492 million with a record margin of 52.5%.
Cash Flow and EPS Performance
Cash flow from operating activities rose by almost 10% to R$470 million, and EPS increased by 23% year-over-year, reaching R$2.79.
Significant Increase in Medical Students and Seats
The number of Undergrad Medical students grew by almost 50% compared to the first quarter of 2024, with approved medical seats increasing to 3,653 after the Funic acquisition.
Credit Rating Upgrade and ESG Recognition
Moody’s upgraded Afya’s national scale credit rating from AA+.br to AAA.br with a stable outlook, and MSCI awarded a BBB ESG rating.
Growth in Medical Practice Solution and Continuing Education Segments
Net revenue for Medical Practice Solution increased by 14%, and Continuing Education saw a 9% growth year-over-year.

Afya (AFYA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AFYA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 14, 2025
2025 (Q2)
0.34 / -
2.29
May 09, 2025
2025 (Q1)
0.47 / 0.57
0.48416.79% (+0.08)
Mar 13, 2025
2024 (Q4)
0.28 / 0.37
0.31617.32% (+0.05)
Nov 13, 2024
2024 (Q3)
0.32 / 0.32
0.24429.71% (+0.07)
Aug 15, 2024
2024 (Q2)
0.34 / 0.40
0.25161.27% (+0.15)
May 09, 2024
2024 (Q1)
0.42 / 0.48
0.31354.80% (+0.17)
Mar 14, 2024
2023 (Q4)
0.27 / 0.32
0.24429.71% (+0.07)
Nov 13, 2023
2023 (Q3)
0.24 / 0.24
0.2267.81% (+0.02)
Aug 28, 2023
2023 (Q2)
0.23 / 0.25
0.22212.88% (+0.03)
May 24, 2023
2023 (Q1)
0.28 / 0.31
0.2994.49% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AFYA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 09, 2025
$19.40$19.61+1.08%
Mar 13, 2025
$16.01$17.80+11.18%
Nov 13, 2024
$17.08$15.95-6.62%
Aug 15, 2024
$17.52$18.68+6.62%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Afya (AFYA) report earnings?
Afya (AFYA) is schdueled to report earning on Aug 14, 2025, TBA Not Confirmed.
    What is Afya (AFYA) earnings time?
    Afya (AFYA) earnings time is at Aug 14, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AFYA EPS forecast?
          AFYA EPS forecast for the fiscal quarter 2025 (Q2) is 0.34.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis